Literature DB >> 34064124

Ultrasound Elastography-Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment.

Andrej Hari1.   

Abstract

Metabolic dysfunction-associated fatty liver disease has become the most common chronic liver disease as well as the most common cause for liver transplantation. With its different methods types, elastography of the liver can be used for non-invasive evaluation of the liver fibrosis and steatosis degree. The article focuses on the description, use, advantages, and limitations of the currently known elastographic techniques. It proposes a simple risk assessment algorithm for the liver fibrosis progress evaluation. The following is an overview of the use of liver and spleen elastography in the detection of clinically relevant portal hypertension. It concludes with research and technological possibilities that could be important to the field in the upcoming years.

Entities:  

Keywords:  elastography; liver fibrosis; liver steatosis; non-invasive assessment; portal hypertension

Mesh:

Year:  2021        PMID: 34064124     DOI: 10.3390/medicina57060516

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  42 in total

1.  Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.

Authors:  Jing-Houng Wang; Hsin-You Ou; Yi-Hao Yen; Chien-Hung Chen; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

2.  Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease.

Authors:  Ivica Grgurevic; Nermin Salkic; Anita Madir; Gorana Aralica
Journal:  Liver Int       Date:  2020-03-17       Impact factor: 5.828

3.  Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.

Authors:  Arthur Berger; Federico Ravaioli; Oana Farcau; Davide Festi; Horia Stefanescu; François Buisson; Pierre Nahon; Christophe Bureau; Nathalie Ganne-Carriè; Annalisa Berzigotti; Victor de Ledinghen; Salvatore Petta; Paul Calès
Journal:  Clin Gastroenterol Hepatol       Date:  2020-06-17       Impact factor: 11.382

4.  Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.

Authors:  David Petroff; Valentin Blank; Philip N Newsome; Cosmin Sebastian Voican; Maja Thiele; Victor de Lédinghen; Stephan Baumeler; Wah Kheong Chan; Gabriel Perlemuter; Ana-Carolina Cardoso; Sandeep Aggarwal; Magali Sasso; Peter J Eddowes; Michael Allison; Emmanuel Tsochatzis; Quentin M Anstee; David Sheridan; Jeremy F Cobbold; Sylvie Naveau; Monica Lupsor-Platon; Sebastian Mueller; Aleksander Krag; Marie Irles-Depe; David Semela; Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Cristiane A Villela-Nogueira; Harshit Garg; Olivier Chazouillères; Johannes Wiegand; Thomas Karlas
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01-15

5.  Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.

Authors:  Georg Semmler; Katharina Wöran; Bernhard Scheiner; Lukas Walter Unger; Rafael Paternostro; Judith Stift; Philipp Schwabl; Theresa Bucsics; David Bauer; Benedikt Simbrunner; Albert Friedrich Stättermayer; Matthias Pinter; Michael Trauner; Thomas Reiberger; Mattias Mandorfer
Journal:  United European Gastroenterol J       Date:  2020-01-17       Impact factor: 4.623

Review 6.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Laurent Castera; Mireen Friedrich-Rust; Rohit Loomba
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

Review 7.  Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.

Authors:  Rafael Paternostro; Thomas Reiberger; Theresa Bucsics
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

8.  Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard.

Authors:  Sun Kyung Jeon; Ijin Joo; So Yeon Kim; Jong Keon Jang; Juil Park; Hee Sun Park; Eun Sun Lee; Jeong Min Lee
Journal:  Ultrasonography       Date:  2020-05-09

Review 9.  Imaging biomarkers of NAFLD, NASH, and fibrosis.

Authors:  Veeral Ajmera; Rohit Loomba
Journal:  Mol Metab       Date:  2021-01-15       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.